NICE recommends new treatment option for MS
Posted: Wed Aug 27, 2014 7:22 am
NICE recommends new treatment option for multiple sclerosis Tecfidera (Dimethyl fumarate)
In final guidance, the National Institute for Health and Care Excellence (NICE) has recommended the use of Biogen Idec’s multiple sclerosis drug, dimethyl fumarate (also called Tecfidera).
The NHS now has a legal obligation to begin funding this treatment for eligible patients within the next 3 months...... Read More - http://www.ms-uk.org/tecfidera
In final guidance, the National Institute for Health and Care Excellence (NICE) has recommended the use of Biogen Idec’s multiple sclerosis drug, dimethyl fumarate (also called Tecfidera).
The NHS now has a legal obligation to begin funding this treatment for eligible patients within the next 3 months...... Read More - http://www.ms-uk.org/tecfidera